Sign in

Research summary ·

Follow-Up 18F-Fluorodeoxyglucose Positron Emission Tomography in Treated Patients With Giant Cell Arteritis: A Systematic Review and Metaanalysis.

Written based on 1 research study on PubMed, searched on 15 Nov 2026.

What was studied

This study looked at giant cell arteritis that affects large blood vessels. It asked if a PET scan can track the disease after treatment. The team searched several research databases up to February 29, 2024. They then pooled results from 25 studies. All people had active disease on a first scan. Each then got stronger drugs that calm the immune system, and a second scan.

What they found

The search found 3131 records, and 25 studies were used. In people who got better, the second scan almost always looked better too. The pooled score for a better scan was 0.95. For a fully normal scan in people in remission, it was 0.53. People treated with tocilizumab did better on both counts. Their scores were 1.00 and 0.78.

What it means for patients

The authors say scans got better in most people whose disease improved. Yet the vessels looked fully quiet on the scan in only some of them. So in remission, many scans did not look fully normal. Responses looked better in people on tocilizumab.

Why it is not certain yet

This is a review that pooled 25 studies. A review can only be as good as the studies in it. The abstract does not say how many people took part in total. It gives a broad range for the normal-scan result, from 0.34 to 0.72. The tocilizumab results come from only a subgroup of people. The abstract gives no results for people who did not improve.

Source

Follow-Up 18F-Fluorodeoxyglucose Positron Emission Tomography in Treated Patients With Giant Cell Arteritis: A Systematic Review and Metaanalysis.

PubMed · PMID 42140639

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Giant cell arteritis publications